CytoMed Therapeutics Limited — Cash Flow (NASDAQ:GDTC)

Financials

Cash from operating activities -1.04 M-2.6 M-1.98 M-2.88 M — Cash from investing activities -353.11 K-2.14 M824.58 K722.67 K — Cash from financing activities 722.71 K8.28 M-47.5 K162.26 K — Free cash flow -1.04 M-2.6 M-1.98 M-2.88 M —

뉴스

사이토메드, 말레이시아 임상 시험 파트너십 발표 후 주가 급등

CytoMed stock jumps after announcing clinical trial partnership in Malaysia

CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital

사이토메드, 자회사에 50만 달러 투자 유치

CytoMed Therapeutics secures $500,000 investment for subsidiary

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

사이토메드, 백혈병 치료제 전임상 결과 발표

CytoMed reports promising preclinical results for leukemia treatment

CytoMed Therapeutics shareholders approve all proposals at annual meeting

CytoMed Therapeutics schedules annual shareholder meeting